These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7710242)

  • 1. An update on the malignant hyperthermia syndrome.
    Rosenberg H; Fletcher JE
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):84-97. PubMed ID: 7710242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia.
    Denborough M
    Lancet; 1998 Oct; 352(9134):1131-6. PubMed ID: 9798607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
    Schuster F; Johannsen S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperthermia: a review.
    Rosenberg H; Pollock N; Schiemann A; Bulger T; Stowell K
    Orphanet J Rare Dis; 2015 Aug; 10():93. PubMed ID: 26238698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia.
    Ali SZ; Taguchi A; Rosenberg H
    Best Pract Res Clin Anaesthesiol; 2003 Dec; 17(4):519-33. PubMed ID: 14661655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
    Fletcher JE; Calvo PA; Rosenberg H
    Br J Anaesth; 1993 Sep; 71(3):410-7. PubMed ID: 8398525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia: responses of skeletal muscles to general anesthetics.
    Gallant EM; Ahern CP
    Mayo Clin Proc; 1983 Nov; 58(11):758-63. PubMed ID: 6355673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium sulfate - An effective agent could delay the progression of fulminant malignant hyperthermia.
    Xu X
    Med Hypotheses; 2019 Mar; 124():118-120. PubMed ID: 30798905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant Hyperthermia - Update on Pathophysiology, Diagnostics and Treatment].
    Johannsen S; Schuster F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):527-537. PubMed ID: 31525786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
    Nelson TE; Lin M; Zapata-Sudo G; Sudo RT
    Anesthesiology; 1996 Jun; 84(6):1368-79. PubMed ID: 8669678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model].
    Jantzen JP; Eberle B; Gaida BJ; Hennes HJ; Otto S; Schäfer M
    Anaesthesist; 1992; 41(5):248-53. PubMed ID: 1616114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine.
    Lopez JR; Allen P; Alamo L; Ryan JF; Jones DE; Sreter F
    Cell Calcium; 1987 Oct; 8(5):385-96. PubMed ID: 3427616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
    Ben Abraham R; Cahana A; Krivosic-Horber RM; Perel A
    QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
    Helf D; Schneiderbanger D; Markus CK; Johannsen S; Schuster F
    Anaesthesist; 2018 Apr; 67(4):275-279. PubMed ID: 29480319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.